Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
4 Must-Visit bar-b-que Eateries This Year05.06.2024 - 2Bismuth’s haredi draft bill won’t change enlistment, IDI expert tells 'Post'30.11.2025
- 3FDA approves Wegovy pill for weight loss: What to know23.12.2025
- 4Paratroopers kill terrorist who threw rocks at Israeli citizens, soldiers near Ofra in West Bank23.11.2025
- 537 Things Just Individuals Experiencing childhood during the 80s Will Comprehend02.12.2015
- 2 new malaria treatments announced as drug resistance grows
- Research institutions tout the value of scholarship that crosses disciplines – but academia pushes interdisciplinary researchers out
- Shrewd Home Gadgets to Save Energy
- Well known Travel Booking Locales: What's Your Pick?
- In the background: Visiting Notable Film Areas All over the Planet
- Best Internet based Course for Learning Another Dialect: Which Stage Do You Like?
- Signature Scents: A Manual for Outstanding Fragrances
- Supreme Court case about ‘crisis pregnancy centers’ highlights debate over truthful advertising standards
- The Response to Independence from the rat race: Methodologies for Creating Financial momentum
